NCT06755151View on ClinicalTrials.gov

Fenofibrate in Primary Biliary Cholangitis: a Real World Study

PHASE3RecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions

Primary Biliary Cholangitis (PBC)

Interventions

DRUG

Fenofibrate

Fenofibrate 200mg

Trial Locations (1)

Unknown

RECRUITING

Xijing hospital, Xi'an

All Listed Sponsors

lead

Xijing Hospital of Digestive Diseases

OTHER